Alpine Immune Sciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Alpine Immune Sciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 96% to $58,876,000. The net income raised on -$32,183,999 and profit margin reached -55%. Total operating expenses were $103,126,000.

Profit Margin

Alpine Immune Sciences, Inc. (NASDAQ:ALPN): Profit margin
2014 0 -15.03M
2015 492K -22.81M -4637.8%
2016 2.95M -31.46M -1066.54%
2017 1.73M -7.78M -449.62%
2018 705K -36.48M -5175.46%
2019 1.74M -42.53M -2444.48%
2020 9.33M -27.94M -299.3%
2021 23.44M -50.33M -214.7%
2022 30.06M -57.76M -192.13%
2023 58.87M -32.18M -54.66%

ALPN Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
58.87M30.06M23.44M9.33M1.74M705K1.73M2.95M492K0
Cost of revenue
80.90M597K620K27.18M35.84M28.97M10.62M143K66K0
Gross profit
-22.02M29.46M22.82M-17.85M-34.10M-28.26M-8.89M2.80M426K0
Operating exp.
Research and development
80.90M70.24M58.74M27.18M35.84M28.97M10.62M23.31M16.05M12.19M
Selling and marketing
0000000000
Total operating expenses
103.12M88.21M73.30M38.08M45.31M37.33M16.70M31.90M22.89M14.48M
Operating income
-44.25M-58.14M-49.85M-28.74M-43.57M-37.83M-14.97M-31.90M-22.89M-14.48M
Other income (expenses), net
12.16M2.71M-561K803K1.72M-1.20M6.99M439K80K-548.75K
Income before tax
-32.08M-55.43M-50.42M-27.94M-41.85M-36.85M-7.98M-31.46M-22.81M-15.03M
Income tax expense
103K2.33M-87K-6K682K-366K-200K-143K-66K1.14M
Net income
-32.18M-57.76M-50.33M-27.94M-42.53M-36.48M-7.78M-31.46M-22.81M-15.03M
Earnings per share
Basic EPS
-0.64-1.73-1.98-1.34-2.32-2.63-1.2-8.12-9.74-6.59
Diluted EPS
-0.64-1.73-1.98-1.34-2.32-2.63-1.2-8.12-9.74-6.59
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source